Other safety alerts
|
| |
| Australia: Counterfeit weight loss products claiming to contain GLP-1 |
| |
The Therapeutic Goods Administration (TGA) is issuing an updated safety advisory after testing confirmed counterfeit imported weight loss products. These products falsely claim to contain glucagon-like peptide-1 (GLP-1) receptor agonists or GLP-1 analogues, posing potential risks to health.
This follows an earlier warning related to imported unregistered GLP-1 weight-loss products. TGA laboratory testing of several imported unregistered products has confirmed that the products contain no GLP-1 or any GLP-1 analogues, despite being labelled as such:
- STDEI GLP-1 Weight Loss Oral Solution
- BuildLeaf – Tirzepatide GLP-1 Herbal Oral Liquid
- HHVB GLP-1 Six In-One Health Solution Oral Liquid
- EQVP GLP-1 Six In-One Health Solution Oral Liquid
- Diapason GLP-1 Seven In-One Health Solution Oral Liquid
- BuildLeaf GLP-1 Eight-In-One Fit & Vital Oral Solution
- LERCEA GLP-1 Metabolic Balance Oral Ampoules
- Croaie Tipoleptide GLP-1 + GIP Weight Management
- HHVB-GLP-1 Nano Microneedle Patch
- HHVB GLP-1 Moringa Slimming & Health Boost Drops
GLP-1 receptor agonists (like semaglutide, tizepatide, liraglutide) are prescription-only medicines in Australia and should only be used under medical supervision. The products tested by the TGA are considered counterfeit under the Therapeutic Goods Act 1989 and are not included in the Australian Register of Therapeutic Goods (ARTG). Using counterfeit GLP-1 products can expose you to serious financial and safety risks.
Consumers are advised not to use any GLP-1 product unless advised or prescribed by a healthcare professional. If you have any concerns arising from your use of these or similar products, consult your healthcare practitioner. For your safety, only buy prescription medicines from a local registered pharmacy. Do not buy unregistered GLP-1 products through social media or other digital platforms.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/safety-monitoring-and-information/../counterfeit-weight-loss-products-claiming-contain-glp-1
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by TGA, and was posted on the Drug Office website on 30 Sep 2025.
Ends/Monday, Mar 2, 2026
Issued at HKT 14:45
|
| |
|
